DOI resolved by resea
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol on resea.org. DOI 10.1016/s0140-…
Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen
https://resea.org/10.1016/s0140-6736(02)08089-3